corydalmine has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies
| Studies (corydalmine) | Trials (corydalmine) | Recent Studies (post-2010) (corydalmine) | Studies (enkephalin, ala(2)-mephe(4)-gly(5)-) | Trials (enkephalin, ala(2)-mephe(4)-gly(5)-) | Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 2,727 | 1 | 374 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YN; Dai, WL; Jiang, N; Liu, JH; Liu, XT; Yan, B; Yu, BY | 1 |
1 other study(ies) available for corydalmine and enkephalin, ala(2)-mephe(4)-gly(5)-
| Article | Year |
|---|---|
Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner.
Topics: Analgesics, Opioid; Animals; Berberine; Cell Line, Tumor; CHO Cells; Chronic Pain; Cricetinae; Cricetulus; Dopamine Antagonists; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Male; MAP Kinase Signaling System; Mice; Morphine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Opioid, mu | 2018 |